Summary.-Lymph node and peripheral blood lymphocytes were studied simultaneously for surface markers of T and B cells in 22 patients with lymphoproliferative diseases and 8 patients with non-neoplastic lymphadenopathy. This resulted in the classification of the malignancy from involved lymph nodes into 4 groups. Six patients had B cell lymphomata with normal or strong immunofluorescent staining for surface membrane immunoglobulin; 8 patients had B cell chronic lymphocytic leukaemia with pale staining for surface membrane immunoglobulin; 5 patients had T cell lymphomata and 3 patients were not definitely classifiable.
THE RECOGNITION of surface markers on T and B cells has permitted an additional classification of lymphoproliferative disease into malignancies of T or B cell origin (Hansen and Good, 1974) . The malignant lymphocyte in most patients with chronic lymphocytic leukaemia (CLL) has been shown to be of monoclonal B cell origin (Seligmann, Preud'Homme and Brouet, 1973) . By the study of peripheral blood, the B cell origin of the malignant lymphocyte from a minority of patients with non-Hodgkin's lymphoma has also been confirmed (Aisenberg and Bloch, 1972; Gajl-Peczalska et al., 1973; Piessens et al., 1973) . A small number of patients with lymphoproliferative disease of T cell origin has been described (Seligmann et al., 1973; Smith et al., 1973; Yodoi et al., 1974) .
Examination of peripheral blood in many patients with lymphoproliferative disease does not allow the identification of the malignant lymphocyte because sufficient numbers of such cells may not be circulating. The spectrum of lymphoproliferative disease includes patients with high peripheral blood lymphocyte counts classified as CLL and those with relatively normal counts and large tumour masses referred to as lymphocytic lymphoma (LL), but there exists an intermediate group with modestly raised counts and tumour mass which is difficult to classify.
There have been few studies of malignant lymphocyte surface markers in the main lymphoid organs (lymph nodes and spleen) where the bulk of tumour occurs (Jaffe et al., 1974; Peter, Mackenzie and Glassy, 1974) . For this reason the present study was undertaken in an attempt to classify the neoplasms into T or B cell type by examination of surface markers of lymphocytes in the histopathologically involved lymph nodes. Attempts were also made to correlate these immuno-logical findings with the morphological findings in the involved lymph nodes and to see if the intermediate group of patients with lymphoproliferative disorders, referred to above, could be further categorized.
MATERIALS AND METHODS
Patients-Twenty-tw o patients with variotIs lymphoproliferative disorders and 8 patients with non-neoplastic lymphadenopathy wNere studied by simultaneous examination of peripheral blood and surgically removed lymph nodes. The diagnoses were LL (14 patients), CLL (7), Waldenstroin's macroglobulinaemia (1), recent viral infection (4), incidental lymph nodes removed at surgery (2), dermatopathic lymphadenopathy (1) and anaerobic diphtheroid infection (1). The distinction between LL and CLL was made on the basis of peripheral blood lymphocyte count and lymph node tumour mass, a relatively normal lymphocyte count (in untreated patients) with large lymph node masses favouring the cliniical diagnosis of LL. Of the 22 patients with lymphoproliferative disorders, 8 had been previously treated with corticosteroids, alkylating agents and/or radiotherapy.
Controls.-Peripheral blood from 78 adult hospital and laboratory staff was used to establish a normal range.
Histopathology.-The excised lymph nodes were cut, one portion being processed for routine histopathology, the other for immunological testing. Those patients with malignant lymphoma were classified according to Rappaport (1966) . The results reported in this study of patients with lymphoproliferative disease are derived only from those with lymph nodes which were shown to have the architectural changes diagnostic of malignant lymphoma.
Lymphocyte counts-Total white cell counts were obtained using a Coulter S automated counter. Differentials were performed on 200 wlhite cells in stained films.
Lymphocyte isolation.-The portions of lymph nodes for immunological study were gently teased with fine forceps in calcium and magnesium-free Dulbecco phosphate buffered saline (PBS) (Commonwealth Serum Laboratories, C.S.L., Melbourne, Australia). The resulting cell suspension was placed on Ficoll-(Pharmacia, Sydney, Australia), Hypaque (Winthrop, Sydney, Australia) gradients according to the method of Boyum (1968) and the mononuclear cells collected and washed 3 times with PBS. Peripheral blood mononuclear cells were similarly isolated. Mononuclear cell preparations were at least 9000 viable by trypan blue exclusion. E rosette forming lymphocytes (E-RFL). T cells were determined by non-immune rosette formation (Special Technical Report, 1974 (Shevach, Jaffe and Green, 1973; Froland and Natvig, 1973 Yamamoto and Kawamura (1970) and were centrifuged at high speed for 10 min just before use to remove possible aggregates.
Three times PBS washed lymphocytes w%Aere mixed with a previously determined optimal dilution of conjugated antiserum for 30 min at 4°C. The mixture was washed 3 times with cold PBS and one drop of glycerol wras added to the pellet. At least 200 cells in suspension were counted using a Reich-ert Zetopan fluorescence microscope equipped with epi-illumination, SP3 mercury vapour lamp and 63 times immersion objective. Cells wvere first identified as lymphocytes under phase contrast. Intensity of staining was described as pale, normal or strong compared wxvith control lymphocytes.
This was performed according to a technique previously described (Ziegler, Hansen and Penny, 1975) 
DISCUSSION
By studying the lymphocytes in the lymph nodes of 22 patients with lymphoproliferative disorders for surface markers on T and B cells, it has been possible to classify these diseases into 4 distinct groups: B cell lymphomata (6 patients), B cell CLL (8), T cell lymphomata (5) and unclassifiable lymphomata (3). Eleven patients could have been classified by examination of peripheral blood alone-B cell lymphoma (3), B cell CLL (8). In 3 patients the origin of the malignant cell was uncertain from examination of both tissues. These findings are in agreement with other series (Gajl-Peezalska et al., 1973; Piessens et al., 1973) of nonHodgkin's lymphoma, where only onethird of the patients were classified as B cell lymphoma by examination of peripheral blood alone. It can be seen that the yield of positive classifications approaches 80% if lymph node lymphocytes are studied, which is in agreement with the findings of Aisenberg and Bloch (1972); Seligmann et al. (1973); Huber et al. (1974) and Peter et al. (1974) . It is possible that 2 patients studied after treatment of B cell lymphoma may have manifested circulating lymphoma cells before commencement of therapy.
It has been reported that intensity of staining by IF (Seligmann et al., 1973) or by autoradiography (Wilson and Hurdle, 1973; Huber et al., 1974 ) is a good indicator of the type of B cell proliferation. This is confirmed in this series where normal or strong staining for SmIg by IF was characteristic of relatively normal peripheral blood lymphocyte counts and large tumour mass, the type of disease classified as LL. B cell CLL is characterized by high peripheral blood lymphocyte counts and pale or absent staining for SmIg. It was possible to classify 4 intermediate group patients with lymphocyte counts between 60001,ul and 10,000/,i as CLL in 2 on the basis of pale staining for SmIg in peripheral blood and lymph node, and as LL in 2 with normal or strong staining for SmIg in blood and lymph node. It is possible that pale surface staining is another manifestation of the surface membrane abnormality in CLL which has been suggested to explain other findings of impaired recirculation and cap formation (Flad et al., 1973) .
Owing to our lack of monospecific light chain antisera, the previously reported monoclonal nature (Seligmann et al., 1973) of the malignant lymphocyte in B cell lymphoma and B cell CLL could not be confirmed. Although the heavy chain antisera were checked for specificity in the conventional ways, these methods may not guarantee monospecificity as has been recently suggested (Special Technical Report, 1974) . This problem may have resulted in many B cell CLL patients in this series staining with antisera to more than one heavy chain class. It was possible to classify these lymphoproliferations with certain commercially available antisera, an advantage for the nonresearch laboratory.
It has been suggested that the malignant lymphocyte may not display normal surface markers (Seligmann et al., 1973; Hansen and Good, 1974) . Such phenomena may explain several anomalies in this study. Firstly, the patients with B cell lymphomata had relatively decreased percentages of EA-RFL, which may reflect an abnormal balance between SmIg and the Fe receptor in these lymphocytes. Secondly, many of the patients with B cell CLL had increased numbers of Fc receptor positive cells identified as EA-RFL, many of which had less than the defined number of SRBC surrounding the lymphocyte (Table III) . This may reflect a low affinity Fc receptor or decreased density of Fc receptors on the malignant cell. Thirdly, it has been shown that a malignant cell may display both T and B cell markers (Shevach et al., 1973; Brouet and Prieur, 1974 (1973) , who had a T cell lymphoma, T cell origin in this patient is less likely because of a low percentage of E-RFL.
The identification of 5 out of 14 lymphomata as T cell in origin in this series, emphasizes the importance of examination of the lymph nodes in view of the rarely reported occurrence of T cell lymphoproliferative disease (Seligmann et al., 1973; Smith et al., 1973; Yodoi et al., 1974) . The lymph node T cell percentage in this group was not always greater than 70%, as emphasized by Peter et al. (1974) but this may be explained by our stricter criterion of 4 SRBC for a positive E-RFL. A higher T cell percentage may have been reached had only 3 SRBC been taken for a positive E-RFL. These patients all had poorly differentiated cells on histopathology, which may have been the explanation for severely reduced PHA responsiveness in 2 of 3 patients tested in this group. Nodular lymphoma has been previously shown to be of B cell origin (Jaffe et al., 1974) but in one patient in the series of Peter et al. (1974) and one in this series, a nodular lymphoma of T cell origin is described. It would be more definitive to study such nodular lymphomata in tissue sections if a good T cell marker for use in such sections were available.
Three of 22 patients with lymphoproliferative disorders who came to splenectomy had nodular replacement of the spleen by lymphoma. Splenic mononuclear cells obtained in a similar maimLer to lymph node cells were studied but a corresponding classification of T or B cell origin was not possible due to the unavoidable contamination of the nodules with perinodular red pulp mononuclear cells. Two of 3 patients with nonneoplastic lymphadenopathy and high T cell percentages in the lymph node had recent infectious mononucleosis. The circulating atypical lymphocyte in this disease has been shown to be of a T-cell origin (Sheldon et al., 1973) and these findings support this observation.
Towards the latter part of this study some patients with lymphadenopathy could be confidently and easily dia,gnosed on the day of lymph node biopsy by examination of T 
